Brookline Capital Acquisition announced that, starting Feb. 22, holders of the units sold in the PSAC’s IPO may elect to trade shares and warrants separately. Common stock and warrants that are separated will trade on Nasdaq under BCAC and BCACW, respectively. Those units not separated will continue to trade under BCACU.
The SPAC raised $57.5 million in an IPO last month.
Brookline is targeting life science companies in the United States and Europe. Read more.
